The Danger of No Antitrust Enforcement: How a Merger Led to the US Ventilator Shortage

In order to enhance its market power, a large medical device manufacturer and distributor named Covidien bought up the small and competitive Newport Medical in 2012, canceled its federal contract to manufacture 40,000 ventilators, and shut down its ventilator business. That acquisition was part of longstanding consolidation in the medical industry that left the United States unprepared to face the pandemic.

Read more

The Stimulus Package Is Too Expensive and Poorly Targeted: The Waste Contained in the CARES Act

A cost-effective stimulus to mend the effects of a 24 percent drop in GDP would cost no more than $1.3 trillion over a 6-month period. The bill that Congress just approved is much bigger because it allocates resources to people who are not necessarily affected and rescuing businesses, like Boeing, that are in trouble for pre-existing reasons.

Read more

The Economics of the Covid-19 Bailout: a Webinar

Princeton Professor Markus Brunnermeier and Nellie Liang, the former director of the Division of Financial Stability at the Federal Reserve, discuss the legacy of policy reaction to the 2008 global financial crisis and why this crisis is different. What is the limit of Fed intervention? What is the role of the Treasury in emergency liquidity programs? How do new measures to support corporate credit work?

Read more

This Is Not a Financial Crisis, So Why Should We Bailout Wall Street (Again)?

Republican and Democratic Senators reached a deal on a $2 trillion bill to help businesses and people hit by the coronavirus outbreak. But the bill also includes slush funds to bail out market funds and guarantee trillions of dollars of risky bank debt. At the same time, millions of small and medium-sized businesses are going to have no access to cash and revenue freezes, because of the pandemic and economic restrictions.

Read more